CompletedNCT01455961
Real-World Treatment Patterns in Bipolarity Care in Sweden
About this title
An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder
Read the official source — NCT01455961Observational study
Understand this study
Who was this study for?
This study was for people with bipolarity. Other eligibility criteria applied.
Study information
Study start dateNovember 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 16,000
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- Not clearly listed
- Age range
- Not clearly listed
- Official registry ID
- NCT01455961
- Official title
Show the full official title
An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder Treated With Quetiapine XR and/or Quetiapine IR
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedLocations not listed
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Who was this study for?
This study was for people with bipolarity. Other eligibility criteria applied.
